CoChat

Mild cognitive impairment and cognitive impairment, no dementia: Part A, concept and diagnosis

Chertkow, Howard, Nasreddine, Ziad, Joanette, Yves, Drolet, Valérie, Kirk, John, Massoud, Fadi, Belleville, Sylvie, Bergman, Howard · 2007 · Alzheimer's & Dementia
Cited by 116

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

Mild cognitive impairment (MCI) and cognitive impairment, no dementia (CIND) are controversial emerging terms that encompass the clinical state between elderly normal cognition and dementia. This article reviews recent work on the classification of MCI and CIND, their prognosis, and diagnostic approaches and presents evidence‐based recommendations approved at the meeting of the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD3) held in Montreal in March, 2006. New short tools such as the Montreal Cognitive Assessment are making it easier for family physicians to confidently attach the label of MCI.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2007.07.013

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Research works printed but not linked: 111

  1. 10.1016/0197-2456(95)00134-4 · DOI · Paper page
  2. 10.1016/0895-4356(90)90073-X · DOI · Paper page
  3. CSHA, 2000, The incidence of dementia in Canada: the Canadian Study of Health and Aging Working Group, Neurology, 55, 66, 10.1212/WNL.55.1.66 · DOI · Paper page
  4. McKann G., 1984, Clinical diagnosis of Alzheimer's disease: report of the NINCDS‐ADRDA work group under the auspices of the Department of Health Services Task Force on Alzheimer's disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 · DOI · Paper page
  5. 10.1080/87565648609540348 · DOI · Paper page
  6. 10.1080/87565648909540440 · DOI · Paper page
  7. 10.1111/j.1532-5415.1995.tb05565.x · DOI · Paper page
  8. 10.1080/13825589608256617 · DOI
  9. Salthouse T.A., 1991, Theoretical perspectives on cognitive aging, 438
  10. 10.1212/WNL.56.11.1533 · DOI · Paper page
  11. 10.1093/geronb/51B.4.P217 · DOI · Paper page
  12. 10.1076/clin.14.4.504.7200 · DOI
  13. 10.1016/S0140-6736(97)01007-6 · DOI · Paper page
  14. 10.1001/archneur.1995.00540300086018 · DOI · Paper page
  15. 10.1001/archneur.60.4.577 · DOI · Paper page
  16. 10.1159/000071189 · DOI · Paper page
  17. 10.1176/appi.ajp.159.3.436 · DOI · Paper page
  18. 10.1111/j.1532-5415.1985.tb07109.x · DOI · Paper page
  19. Reisberg B., 1988, Global Deterioration Scale (GDS), Psychopharmacol Bull, 24, 661
  20. 10.1002/1099-1166(200011)15:11<983::AID-GPS238>3.0.CO;2-5 · DOI · Paper page
  21. 10.1002/gps.930070705 · DOI · Paper page
  22. 10.1111/j.1532-5415.1993.tb06448.x · DOI · Paper page
  23. 10.1017/S1041610294001626 · doi:10.1017/s1041610294001626
  24. Smith A.D., 1996, Use of structural imaging to study the progression of Alzheimer's disease, Br Med Bull, 52, 3, 10.1093/oxfordjournals.bmb.a011568 · DOI · Paper page
  25. 10.1001/archneur.56.3.303 · DOI · Paper page
  26. 10.1001/jama.1995.03520400044042 · DOI · Paper page
  27. 10.1111/j.1365-2796.2004.01388.x · DOI · Paper page
  28. 10.1212/01.WNL.0000132523.27540.81 · DOI · Paper page
  29. Lopez O., 2002, Risk factors for mild cognitive impairment in a population study, Neurology, 58, A238
  30. Chertkow H., 1998, Mild memory loss in the elderly: can we predict development in dementia?, Can J Neurol Sci, 25, 1
  31. 10.1159/000078504 · DOI · Paper page
  32. H.M.Chertkow A.Duong N.Philips H.Bergman L.Babins N.KelnerMild cognitive impairment the danger of basing the diagnosis on published normative groups (P3‐072) Paper presented at ICAD‐Alzheimer's Association 10th International Conference on Alzheimer's Disease and Related Disorders2006 Madrid Spain · doi:10.1016/j.jalz.2006.05.1339
  33. 10.1136/jnnp.2005.085332 · DOI · Paper page
  34. Grundman M., 1996, ADSC Cooperative Study: rate of dementia of the Alzheimer type (DAT) in subjects with mild cognitive impairment, Neurology, 46, A403
  35. 10.1212/01.wnl.0000238517.59286.c5 · DOI · Paper page
  36. 10.1192/bjp.168.4.470 · DOI
  37. 10.1001/archneur.58.3.397 · DOI · Paper page
  38. 10.1212/01.WNL.0000080366.90234.7F · DOI · Paper page
  39. 10.1002/(SICI)1099-1166(200005)15:5<434::AID-GPS137>3.0.CO;2-2 · DOI
  40. 10.1212/WNL.56.1.37 · DOI · Paper page
  41. 10.1016/S0140-6736(99)06155-3 · DOI · Paper page
  42. Chertkow H.M., 1998, Standard neuropsychological tests do not predict development of Alzheimer's Disease in indivduals with “Age‐associated Cognitive Decline”, Can J Neurol Sci, 25, S27
  43. Craik F., 1994, Memory changes in normal aging, Curr Dir Psychol Sci, 3, 1558, 10.1111/1467-8721.ep10770653 · DOI · Paper page
  44. 10.1002/gps.477 · DOI · Paper page
  45. 10.1111/j.1532-5415.2000.tb04992.x · DOI · Paper page
  46. 10.1159/000051284 · DOI · Paper page
  47. 10.1001/jama.281.15.1401 · DOI · Paper page
  48. 10.1001/archneur.57.5.675 · DOI · Paper page
  49. 10.1212/01.WNL.0000089238.07771.C7 · DOI · Paper page
  50. Hsiung G.‐Y., 2002, An analysis of vascular risk factors and ApoE genotype in subtypes of dementia in the ACCORD study, Neurology, 58, A107
  51. 10.1001/archneur.55.8.1065 · DOI · Paper page
  52. 10.1212/WNL.54.7.1492 · DOI · Paper page
  53. 10.1037/0882-7974.13.1.80 · doi:10.1037/0882-7974.13.1.80
  54. 10.1159/000017092 · DOI · Paper page
  55. Corrada M., 2002, Plasma total cholesterol, LDL, HDL levels and the risk of Alzheimer disease: the Baltimore Longitudinal Study of Aging, Neurology, 58, A106
  56. Yaffe K., 2002, Inflammatory markers and cognitive decline in well‐functioning elders: the Health ABC Study, Neurology, 58, A106
  57. Fox N.C., 2000, Increased rates of atrophy in early and preclinical AD: studies with registration of serial MRI, Neurobiol Aging, 21, S74, 10.1016/S0197-4580(00)82552-X · doi:10.1016/s0197-4580(00)82552-x
  58. M.J.deLeon A.Convit.Longitudinal measures of hippocampal formation pathology and CSF measures of phospho‐tau and amyloid beta: early markers for Alzheimer disease Paper presented at Seventh International Geneva/Springfield symposium on advances in Alzheimer Therapy2002 Geneva Switzerland
  59. McKelvey R., 1999, Lack of prognostic significance of SPECT abnormalities in non‐demented elderly subjects with memory loss, Can J Neurol Sci, 26, 23
  60. 10.1212/WNL.55.2.210 · DOI · Paper page
  61. A.Nordberg.PET activation in MCI and AD patients Paper presented at Seventh Annual Springfield/Geneva symposium on advances in Alzheimer Therapy2002 Geneva Switzerland
  62. L.Backman.The cognitive transition from normal aging to AD Paper presented at the Seventh Springfield/Geneva symposium on advances in Alzheimer Therapy2002 Geneva Switzerland
  63. 10.1001/archneur.58.3.411 · DOI · Paper page
  64. 10.1001/archneur.1996.00550050053023 · DOI · Paper page
  65. 10.1111/j.1532-5415.1997.tb00947.x · DOI · Paper page
  66. 10.1176/appi.ajp.157.9.1399 · DOI · Paper page
  67. 10.1017/S1355617701755105 · DOI · Paper page
  68. 10.1212/WNL.53.7.1480 · DOI · Paper page
  69. 10.1212/WNL.54.6.1297 · DOI · Paper page
  70. 10.1016/S0304-3940(99)00617-5 · DOI · Paper page
  71. 10.1212/01.WNL.0000147470.58328.50 · DOI · Paper page
  72. 10.1097/01.wad.0000126613.05674.0c · DOI · Paper page
  73. 10.1016/j.cger.2003.10.001 · DOI
  74. 10.1212/WNL.59.2.198 · DOI · Paper page
  75. 10.1001/archneur.63.1.15 · DOI
  76. 10.1007/s11910-003-0020-2 · DOI
  77. Ritchie K., 2004, Mild cognitive impairment: an epidemiological perspective, Dialogues in Clinical Neuroscience, 6, 401, 10.31887/DCNS.2004.6.4/kritchie · DOI · Paper page
  78. 10.1212/01.WNL.0000034176.07159.F8 · DOI · Paper page
  79. 10.1007/978-3-7091-7508-8_4 · DOI
  80. H.Chertkow.Five year follow‐up of mild cognitive impairment predictors of progression—the 8th International Conference on Alzheimer's Disease and Related Disorders. Stockholm Sweden July2002
  81. 10.1002/gps.1049 · DOI · Paper page
  82. Petersen R.C., 1999, Mild cognitive impairment: clinical characterization and outcome—correction, Arch Neurol, 56, 6, 10.1001/archneur.56.3.303 · DOI · Paper page
  83. 10.1046/j.1440-1614.2002.00972.x · DOI · Paper page
  84. 10.1097/00019442-200508000-00003 · DOI · Paper page
  85. 10.1016/S1474-4422(03)00262-X · DOI · Paper page
  86. 10.1212/01.WNL.0000134664.80320.92 · DOI · Paper page
  87. Jelic V., 2003, Treatment of mild cognitive impairment: rationale, present and future strategies, Acta Neurol Scand Suppl, 179, 83, 10.1034/j.1600-0404.107.s179.12.x · DOI
  88. 10.1002/gps.1042 · DOI · Paper page
  89. 10.1007/s00415-005-0597-2 · DOI
  90. 10.1159/000079198 · DOI
  91. 10.1177/070674370505000110 · DOI
  92. Xu G., 2004, Cross‐cultural comparison of mild cognitive impairment between China and USA, Curr Alzheimer Res, 1, 55, 10.2174/1567205043480564 · DOI
  93. 10.1080/1360786031000120741 · DOI
  94. 10.1001/archneur.60.12.1777 · DOI · Paper page
  95. 10.1073/pnas.0501157102 · DOI · Paper page
  96. 10.1111/j.1532-5415.2005.53269.x · DOI · Paper page
  97. 10.1212/WNL.62.4.556 · DOI · Paper page
  98. 10.1212/WNL.59.7.1042 · DOI · Paper page
  99. 10.1034/j.1600-0404.2002.01225.x · DOI · Paper page
  100. 10.1006/nimg.2001.0992 · DOI
  101. 10.1017/S0033291703007839 · DOI · Paper page
  102. 10.1093/brain/awg236 · DOI · Paper page
  103. Farlow M.R., 2004, Impact of APOE in mild cognitive impairment, Neurology, 63, 1898, 10.1212/01.WNL.0000144279.21502.B7 · DOI · Paper page
  104. 10.1212/01.WNL.0000118301.92105.EE · DOI · Paper page
  105. 10.1212/01.WNL.0000144281.38555.E3 · DOI · Paper page
  106. 10.1080/13554790490896820 · DOI · Paper page
  107. 10.1001/archneur.62.6.975 · DOI · Paper page
  108. Geslani D.M., 2005, Mild cognitive impairment: an operational definition and its conversion rate to Alzheimer's disease, Dement Geriatr Cogn Disord, 19, 383, 10.1159/000084709 · DOI · Paper page
  109. 10.1159/000082351 · DOI · Paper page
  110. 10.1111/j.1532-5415.2005.53566.x · DOI · Paper page
  111. 10.1136/jnnp.2004.047720 · DOI · Paper page

Cited by

See all 116

Metadata

Authors
Chertkow, H., Nasreddine, Z., Joanette, Y., Drolet, V., Kirk, J., Massoud, F., Belleville, S., & Bergman, H.
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2007-10
Volume
3
Issue
4
Pages
266-282
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W1972349970
Cited by
116
References
24
FWCI
4.19
Type
journal article
Language
en
Open access
closed
Funders
  • Canadian Institutes of Health Research (MOP‐15006)
  • Alzheimer Society

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mild cognitive impairment and cognitive impairment, no dementia: Part A, concept and diagnosis. https://app.cochat.ai/papers/10.1016/j.jalz.2007.07.013
The paper
Chertkow, H., Nasreddine, Z., Joanette, Y., Drolet, V., Kirk, J., Massoud, F., Belleville, S., & Bergman, H. (2007). Mild cognitive impairment and cognitive impairment, no dementia: Part A, concept and diagnosis. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2007.07.013

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.